Related Experiment Video
Updated: Jan 31, 2026

Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis
Published on: November 18, 2019
Galectin-9 induces apoptosis in OVCAR-3 ovarian cancer cell through mitochondrial pathway
Seyyed Mehdi Jafari1,2, Ali Nazri3, Mahdi Shabani4
1Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, I.R. Iran.
Abstract:
Galectin-9 (Gal-9), a member of animal lectins' family, is implicated in the induction of apoptosis in various cancer cells. Here, we evaluated the anti-tumor effect of Gal-9 in OVCAR-3 ovarian cancer cells. The effect of the Gal-9 on cell viability was evaluated using MTT assays. Apoptosis was assessed using Annexin-V staining. The assessment of mitochondrial membrane potential (ΔΨm) was performed using a JC-1 probe. The activity of caspase-3 and caspase-6 were evaluated with colorimetric assay. The production of reactive oxygen species (ROS) was applied by fluorescent probe. The expression levels of Bax and Bcl-2 were assessed using western blotting. The result showed that Gal-9 inhibits cell viability. Flow cytometry analysis showed that Gal-9 induces apoptosis in ovarian cancer cells. Moreover, Gal-9 decreased ΔΨm and increased the generation of ROS and caspase-3 and caspase-6 activities in ovarian cancer cells. Moreover, Gal-9 induced expression of Bax as well as inhibited expression of Bcl-2. In conclusion, our results indicated that Gal-9 induced apoptosis in ovarian cancer cells through mitochondrial pathway.
Insights
Galectin-9 (Gal-9) effectively inhibits ovarian cancer cell viability and induces apoptosis. This anti-tumor effect involves the mitochondrial pathway, increasing reactive oxygen species and caspase activity.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Galectin-9 (Gal-9) is a protein implicated in inducing apoptosis in cancer cells.
- Ovarian cancer remains a significant health concern with a need for effective therapeutic strategies.
Purpose of the Study:
- To investigate the anti-tumor effects of Galectin-9 (Gal-9) on OVCAR-3 ovarian cancer cells.
- To elucidate the mechanisms underlying Gal-9-induced apoptosis in ovarian cancer.
Main Methods:
- Cell viability assessed via MTT assays.
- Apoptosis evaluated using Annexin-V staining and flow cytometry.
- Mitochondrial membrane potential (ΔΨm), reactive oxygen species (ROS), and caspase-3/6 activities measured.
- Bax and Bcl-2 protein expression analyzed by western blotting.
Main Results:
- Gal-9 significantly inhibited OVCAR-3 cell viability.
- Gal-9 treatment induced apoptosis in ovarian cancer cells.
- Gal-9 decreased ΔΨm, increased ROS generation, and enhanced caspase-3/6 activities.
- Gal-9 upregulated Bax expression and downregulated Bcl-2 expression.
Conclusions:
- Galectin-9 demonstrates potent anti-tumor activity against ovarian cancer cells.
- Gal-9 induces apoptosis via the mitochondrial pathway.
- The findings suggest Gal-9 as a potential therapeutic agent for ovarian cancer.
Related Concept Videos
Apoptosis
Animal Mitochondrial Genetics
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
Mechanisms of Retrovirus-induced Cancers
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Export of Mitochondrial and Chloroplast Genes

